Status:

COMPLETED

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition

Lead Sponsor:

Dr. Reddy's Laboratories Limited

Conditions:

Healthy

Eligibility:

MALE

18-45 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to determine the pharmacokinetics and bioequivalence of isotretinoin formulations after administration of single doses to normal, non-smoking,healthy males under fed condi...

Detailed Description

An open label, randomized, two-treatment, single dose, oral bioequivalence study of Isotretinoin capsules 40 mg of Dr. Reddy's Laboratories Limited,under fed conditions

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Healthy males between 18 and 45 years of age inclusive.
  • Informed of the nature of the study and given written informed consent.
  • Have a body weight within 15% of the appropriate range as defined in the 1983 Metropolitan Life Company tables and weighing at least 125 lbs. (Appendix I).
  • Exclusion Criteria
  • Hypersensitivity to isotretinoin or related compounds.
  • Any history of a clinical condition which might affect drug absorption, metabolism or excretion.
  • Recent history of mental illness, drug addiction, drug abuse or alcoholism.
  • Donation of greater than 500 ml of blood in the past 4 weeks prior to study dosing or difficulty in donating blood.
  • Received an investigational drug within the 4 weeks prior to study dosing.
  • Currently taking any prescription medication within the 7 days prior to study dosing or over-the-counter medication within 3 days of study dosing. This prohibition does not include vitamins or herbal preparations taken as nutritional supplements for non-therapeutic indications as judged by the attending physician.
  • Regular tobacco use in the 3 months prior to study dosing.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2001

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2001

    Estimated Enrollment :

    26 Patients enrolled

    Trial Details

    Trial ID

    NCT01888328

    Start Date

    May 1 2001

    End Date

    June 1 2001

    Last Update

    June 27 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    AAI

    Quadrangle Drive, Chapel Hill,, North Carolina, United States, 27514